Stereoselective determination of flecainide in human plasma by high-performance liquid chromatography with fluorescence detection.

Enantiomers of a drug may differ in their pharmacological activities or their disposition constants. We now describe a stereoselective analytical method for the determination of the antiarrhythmic agent flecainide in plasma. The resolution of the enantiomers is achieved by high-performance liquid chromatography (HPLC) on a normal phase silica column following derivatization with the optically active reagent (-)-methyl chloroformate. The eluting diastereoisomers are monitored by fluorescence detection at an excitation wavelength of 305 nm and an emission wavelength of 340 nm. The limit of sensitivity for the assay is as low as 2.5 ng/mL for each enantiomer using 1 mL of plasma. A new liquid-liquid extraction procedure with high recovery (greater than 95%) and high selectivity is also reported. The intra- and interassay coefficient of variation for replicated analysis of spiked plasma samples is less than 4.0% and 7.0%, respectively. The method is suitable for single and multiple dose pharmacokinetic studies in healthy volunteers or in patients.

[1]  C. Prakash,et al.  Simultaneous determination of propranolol enantiomers in plasma by high-performance liquid chromatography with fluorescence detection. , 1989, Journal of pharmaceutical sciences.

[2]  D. Roden,et al.  Stereoselective disposition and pharmacologic activity of propafenone enantiomers. , 1989, Circulation.

[3]  C. Prakash,et al.  Resolution of enantiomers of the antiarrhythmic drug encainide and its major metabolites by chiral derivatization and high-performance liquid chromatography. , 1989, Journal of chromatography.

[4]  M. Eichelbaum,et al.  Is there a genetic factor in flecainide toxicity? , 1988, BMJ.

[5]  H. Duff,et al.  Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels. , 1988, Molecular pharmacology.

[6]  B. Sweetman,et al.  3-Nitrobenzyl alcohol has wide applicability as a matrix for FAB-MS. , 1988, Biomedical & environmental mass spectrometry.

[7]  N. Grgurinovich.  A simple high-performance liquid chromatographic method for the routine measurement of flecainide in plasma. , 1988, Journal of analytical toxicology.

[8]  D. Roden,et al.  Drug therapy. Flecainide. , 1986, The New England journal of medicine.

[9]  R. Maes,et al.  Measurement of flecainide plasma concentrations by high performance liquid chromatography with fluorescence detection. , 1986, Journal of analytical toxicology.

[10]  B. Testa.  The chromatographic analysis of enantiomers in drug metabolism studies. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  J. R. Schmid,et al.  Resolution of flecainide acetate, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam ide acetate, and antiarrhythmic properties of the enantiomers. , 1986, Journal of medicinal chemistry.

[12]  G. D. Johnston,et al.  A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers. , 1985, British journal of clinical pharmacology.

[13]  J. Knoll.  Estimation of the limit of detection in chromatography , 1985 .

[14]  H. Boudoulas,et al.  Stereoselective pharmacokinetics of disopyramide enantiomers in man. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[15]  M. Eichelbaum,et al.  Effects of d,l‐verapamil on atrioventricular conduction in relation to its stereoselective first‐pass metabolism , 1985, Clinical pharmacology and therapeutics.

[16]  M. Eichelbaum,et al.  Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. , 1984, British journal of clinical pharmacology.

[17]  B. Lucchesi,et al.  Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. , 1984, Journal of cardiovascular pharmacology.

[18]  J. Johnson,et al.  Quantitation of flecainide acetate, a new antiarrhythmic agent, in biological fluids by gas chromatography with electron-capture detection. , 1984, Journal of pharmaceutical sciences.

[19]  G. Shenfield,et al.  A Rapid Liquid Chromatographic Method for Determination of Flecainide in Human Blood Plasma Using Ultraviolet Detection , 1984 .

[20]  J. Anderson.  Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up. , 1984, The American journal of cardiology.

[21]  D. Roden,et al.  Flecainide dose-response relations in stable ventricular arrhythmias. , 1984, The American journal of cardiology.

[22]  G. Gentzkow,et al.  Extracardiac adverse effects of flecainide. , 1984, The American journal of cardiology.

[23]  D. Holt,et al.  High-performance liquid chromatographic method for the measurement of mexiletine and flecainide in blood plasma or serum. , 1984, Journal of chromatography.

[24]  A. Miller,et al.  Application of a bonded-phase extraction column for rapid sample preparation of flecainide from human plasma for high-performance liquid chromatographic analysis--fluorescence or ultraviolet detection. , 1984, Therapeutic drug monitoring.

[25]  A. Miller,et al.  High-performance liquid chromatographic method for the quantitation of flecainide, a new antiarrhythmic, in human plasma and urine. , 1983, Journal of chromatography.

[26]  W. L. Nelson,et al.  The Cardiac Effects of d‐ and 1‐Disopyramide in Normal Subjects: A Noninvasive Study , 1982, Circulation.

[27]  R. Asinger,et al.  Suppression of Ventricular Ectopic Depolarizations by Flecainide Acetate, A New Antiarrhythmic Agent , 1982, Circulation.

[28]  D. Roden,et al.  Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. , 1981, The American journal of cardiology.

[29]  B. Pitt,et al.  Oral flecainide acetate for the treatment of ventricular arrhythmias. , 1981, The New England journal of medicine.

[30]  J. C. Bailey,et al.  Electrophysiological Effects of the Optical Isomers of Disopyramide and Quinidine in the Dog , 1981, Circulation research.

[31]  J. Westley,et al.  The use of /-/-menthyl chloroformate in the optical analysis of asymmetric amino and hydroxyl compounds by gas chromatography. , 1968 .